Wellixo Pharmaceuticals Private Limited - Company Profile

It is a chemicals and materials private limited company based in Hyderabad, Telangana, India, established in 2016.
2016 Hyderabad, Telangana, India Struck Off
Last Updated:
About Wellixo Pharmaceuticals Private Limited

Wellixo Pharmaceuticals Private Limited, a struck off private limited company, was established on 01 January 2016 in Hyderabad, Telangana, India. Engaging in industrial chemicals within the chemicals and materials sector, it holds CIN: U24233TG2016PTC102517. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Raghuveer Adusumilli (Director), Vijayaprakash Katikala (Director). It is based at H.No. 18-17/1/F-2 Rd No 3 Kamala Nagar Gaddiannaram, Hyderabad, Telangana, 500060.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233TG2016PTC102517

  • Registration Number

    102517

  • Incorporation Date

    01 January 2016

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 1 Month
Company report

Wellixo Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Wellixo Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Wellixo Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Raghuveer Adusumilli Director 01 Jan 2016 Current
Vijayaprakash Katikala Director 01 Jan 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Wellixo Pharmaceuticals.

Enhance accessibility to Wellixo Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Wellixo Pharmaceuticals revenue growth over time
Wellixo Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Wellixo Pharmaceuticals?

Unlock access to Wellixo Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Wellixo Pharmaceuticals?

Unlock and access historical data on people associated with Wellixo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Wellixo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellixo Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Wellixo Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Raghuveer Adusumilli was appointed as a Director was appointed as a Director on 01 Jan 2016 & has been associated with this company since 10 years 1 month . was documented.

  • Director Appointment

    The activity Vijayaprakash Katikala was appointed as a Director was appointed as a Director on 01 Jan 2016 & has been associated with this company since 10 years 1 month . was completed.

  • Company Incorporation

    Wellixo Pharmaceuticals Private Limited was registered on 01 Jan 2016 with Roc Hyderabad & aged 10 years 1 month as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Wellixo Pharmaceuticals Private Limited?

The CIN of Wellixo Pharmaceuticals Private Limited is U24233TG2016PTC102517.

Where is Wellixo Pharmaceuticals Private Limited headquartered?

Wellixo Pharmaceuticals Private Limited is headquartered at H.No. 18-17/1/F-2 Rd No 3 Kamala Nagar Gaddiannaram, Hyderabad, Telangana, 500060.

When was Wellixo Pharmaceuticals Private Limited incorporated?

Wellixo Pharmaceuticals Private Limited was incorporated on 01 January 2016.

Who are the current directors of Wellixo Pharmaceuticals Private Limited?

The current directors of Wellixo Pharmaceuticals Private Limited are

What is the primary industry of Wellixo Pharmaceuticals Private Limited?

The primary industry of Wellixo Pharmaceuticals Private Limited is Chemicals And Materials.

Is Wellixo Pharmaceuticals Private Limited a listed company?

Wellixo Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Wellixo Pharmaceuticals Private Limited?

The authorized capital of Wellixo Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Wellixo Pharmaceuticals Private Limited?

The compliance status of Wellixo Pharmaceuticals Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available